← SynDRA
TAPINAROF
SynDRA canonical compound SYN0008903 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Approval status | Approved · Rx |
| Primary target(s) | AHR | CSNK2A1 | CSNK2B | LCK |
| Mechanism of action | aryl hydrocarbon receptor agonist |
All known targets
Mechanisms of action (all sources)
- AHR AGONIST
- Aryl hydrocarbon receptor agonist
Drug classes
- Aryl Hydrocarbon Receptor Agonist
- Aryl Hydrocarbon Receptor Agonists
- Dermatologic Agents
ATC classes
- D05A · ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- vtama
- GSK2894512
- DMVT-505
- WBI-1001
- Benvitimod
- Vtama
- GSK-2894512
- 3,5-dihydroxy-4-isopropyl-trans-stilbene
- (E)-2-(1-Methylethyl)-5-(2-phenylethenyl)-1,3-benzenediol
- 2-(1-METHYLETHYL)-5-((1E)-2-PHENYLETHENYL)-1,3-BENZENEDIOL
- 3,5-Dihydroxy-4-isopropylstilbene
- 5-((1e)-2-phenylethen-1-yl)-2-(propan-2-yl)benzene-1,3-diol
- 1,3-benzenediol, 2-(1-methylethyl)-5-((1e)-2-phenylethenyl)-
- WBI 1001
- 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol
- 3,5-DH4IS
- tapinarofum
- 5-((E)-2-phenylethenyl)-2-propan-2-ylbenzene-1,3-diol
- 2-(1-Methylethyl)-5-[(1E)-2-phenylethenyl]-1,3-benzenediol
- RefChem:57353
- DTXCID101527189
- 5-(2-phenylethenyl)-2-isopropyl-1,3-benzenediol
- (E)-2-isopropyl-5-styrylbenzene-1,3-diol
- 2-Isopropyl-5-styrylbenzene-1,3-diol
- MFCD13193203
- Tapinarof [USAN]
- 1,3-Benzenediol, 2-(1-methylethyl)-5-[(1E)-2-phenylethenyl]-
- (E)-3,5-Dihydroxy-4-isopropylstilbene
- 1,3-Benzenediol, 2-(1-methylethyl)-5-(2-phenylethenyl)-
- 5-[(1E)-2-phenylethenyl]-2-(propan-2-yl)benzene-1,3-diol
- UNII-84HW7D0V04
- (E)-Benvitimod
- Tapinarof (Standard)
- Vtama (TN)
- Benvitimod (Tapinarof)
- TAPINAROF [INN]
- Tapinarof (JAN/USAN)
- TAPINAROF [WHO-DD]
Reported adverse events
- Abdominal pain
- Application site reaction
- Asthma
- Dermatitis
- Ear infection
- Folliculitis
- Headache
- Influenza
- Lower respiratory tract infection
- Nasopharyngitis
- Pain
- Pain in extremity
Look up TAPINAROF in the interactive SynDRA portal →